Plant inspired medicines developer MGC Pharmaceuticals Ltd (ASX: MGC) has completed the delivery of its largest order of ArtemiC to US distribution and marketing partner, AMC Holdings Inc. (AMC).
Delivery of this large consignment of ArtemiC has now been completed, marking the first substantial commercial delivery of the product under the AMC US supply and distribution agreement to date.
AMC are excited to bring the first commercial order of ArtemiC into the US. It will be available both on-line and through independent pharmacies,” Brent W. Yessin of AMC commented.
“Since the pandemic, the federal government has stopped paying for many treatments the cost burden has shifted to the individual states and consumers. With this change in policy AMC are pleased to be in a position offer the market a natural, plant based and clinically tested treatment option.”
